The medication scans successfully. The electronic medication administration record shows a match. Pharmacy has verified the order. Then the patient says, “I feel much more lightheaded than I did earlier.”
In this hypothetical scenario, you’re preparing to give a scheduled antihypertensive medication. Instead of completing administration, you reassess the patient, obtain current vital signs, review the order’s parameters, and contact the prescriber about the change. The prescription may have been appropriate when written, but the patient needs another assessment now.
The question guiding that assessment is straightforward: Does this medication make sense for this patient, at this dose, at this moment?
The medication administration rights remain essential. Applying them requires you to connect the order and product with the patient’s current condition. Ernstmeyer and Christman describe assessment and evaluation as part of medication administration. At the bedside, that means asking whether the available information supports giving the medication now and what you need to reassess afterward.
Assess the patient before the dose
Start with the indication. Can you explain why this patient is receiving the medication and what response you expect? If the purpose is unclear, consult an approved drug reference or pharmacist before proceeding. Familiarity with a medication doesn’t establish whether the current order fits this patient.
As discussed by Ernstmeyer and Christman, kidney and liver function, age, and interactions can influence medication effects. Review the findings relevant to the drug, including current vital signs, laboratory results, allergies, recent doses, and changes in clinical status. Ask whether an earlier assessment still reflects the patient in front of you.
For example, review the prescribed insulin regimen alongside the current glucose result and nutrition plan. Before an opioid, assess pain, sedation, and respiratory status and review other sedating medications. Use the applicable order, protocol, and drug reference to determine the required assessments. If something has changed, identify what needs clarification before administration.
Turn a concern into a specific question. Instead of “This dose seems wrong,” ask, “Does the change in kidney function require a dose review?” After a procedure, verify what medications were given and when before assuming a scheduled dose remains appropriate. Bring the relevant findings to the pharmacist or prescriber.
Notice when something doesn’t fit
An unexpected concentration, an unfamiliar dose, or a patient’s new symptom deserves attention. Describe the discrepancy and verify it against the order, the patient’s assessment, and an approved reference. The aim is to resolve the concern sufficiently to make a safe decision.
Interruptions can make that reasoning harder. A scoping review by Schroers and colleagues found that most included studies reported a positive association between interruptions and medication administration errors, although definitions and research methods varied. Protect attention during medication checks when possible while keeping urgent clinical communication open. If interrupted, deliberately recheck the information needed to resume safely instead of relying on memory. This is a practical application of interruption awareness, not a validated restart protocol.
Technology provides information to interpret. A longitudinal study of barcode medication administration by Williams and colleagues identified workflow difficulties and equipment problems contributing to nonuse and workarounds. When scanning fails or an alert appears, identify the discrepancy and use the approved escalation process. A familiar warning still needs consideration in the context of this patient.
For an infusion, verify the programmed settings against the order and use the pump’s drug library when applicable, as recommended by the Food and Drug Administration. A setting or alert that doesn’t make sense warrants clarification. A successful scan or accepted pump setting doesn’t resolve a new symptom; in the opening scenario, the lightheadedness still requires assessment.
Listen to the patient and caregiver
Ernstmeyer and Christman encourage nurses to explain the medication’s name and purpose, and invite questions. A patient who says, “That looks different,” or “I already received that,” may offer information that changes the decision. Ask what they usually receive or when the previous dose was given, then verify the explanation before offering reassurance.
Use qualified language assistance when needed. Brach explains that teach-back can help you check how clearly you explained medication information. For example, ask, “To ensure I explained this clearly, tell me what symptoms would make you call us?” Include a caregiver when the patient wishes or when appropriate for developmental or cognitive needs. Patient participation adds information; responsibility for medication verification remains with the clinical team.
Pause and seek a clear decision
When assessment findings raise a safety concern, pause the administration process and communicate promptly. The Agency for Healthcare Research and Quality TeamSTEPPS mutual support guidance supports stating the concern, proposing a solution, and agreeing on next steps. Describe the medication, what changed, the relevant findings, and the decision you need.
In the opening scenario, you might say, “The antihypertensive is due, but the patient now reports lightheadedness and their blood pressure has fallen from the earlier reading. I’ve paused administration for review. Please assess whether to give, delay, or change the dose and specify the reassessment plan.”
The same approach applies to a possible duplicate dose: “The scheduled opioid is due, but the procedure record shows another opioid was given recently and the patient is more sedated than earlier. I’ve paused administration for review. Please clarify the next dose and the monitoring plan.” These hypothetical examples show how to make the clinical concern and requested action explicit.
If the response doesn’t address the risk, restate the concern and escalate through the chain of command using tools such as the TeamSTEPPS two-challenge rule. Its CUS, approach offers language to express Concern, that you’re Uncomfortable, and that the situation is a Safety issue. Choose words that identify the anticipated harm.
A pause needs follow-through. For a time-critical medication, seek immediate assistance so clarification doesn’t become an unnoticed omission. Confirm the decision, obtain required orders, document the communication, and establish who will reassess and when. Follow your scope of practice and facility policies, and respond to deterioration using the applicable emergency process.
Reassess the response
Plan reassessment around the medication’s expected effect and the patient’s risks. Ernstmeyer and Christman recommend evaluating the therapeutic response and possible adverse effects. After an opioid, reassess pain relief alongside sedation and respiratory status. Document the actual administration and relevant response according to policy. If a dose is delayed, omitted, or refused, communicate the follow-up needed.
Returning to the opening scenario, whether the antihypertensive is given, delayed, or changed after review, the new lightheadedness requires follow-up. Confirm the reassessment plan and communicate unresolved concerns at handoff. The medication decision remains connected to the patient’s changing condition.
Keep returning to the question: Does this medication make sense for this patient, at this dose, at this moment? The answer depends on what you assess before administration, what you notice and clarify at the bedside, and how the patient responds afterward.
Five questions for a bedside safety pause
Use these author-developed reflection questions alongside required medication checks. They’re not a validated screening tool and they don’t replace medication-specific assessment or facility protocols.
- Why is this patient receiving this medication, and what response do I expect?
- What current assessment findings could change the decision to give it?
- Have I resolved discrepancies involving the order, product, dose, route, timing, or technology?
- What has the patient or caregiver told me that needs verification?
- What will I reassess afterward, and who needs to know the result?
Nichole Jones is a nursing professional development specialist at Lucile Packard Children’s Hospital Stanford in Palo Alto, California. Her background includes critical care, nursing education, and leadership. Her professional interests include patient safety, clinical judgment, and empowering nurses through education and advocacy.
Korey Jones is a certified pharmacy technician at Stanford Health Care in Palo Alto, California. He holds a Bachelor of Science in psychology. His professional interests include medication safety, narcotic diversion prevention and education, gender-affirming care, and medication education for healthcare workers and patients.
References
Agency for Healthcare Research and Quality. Section 1: overview of mutual support key concepts and tools. July 2023. ahrq.gov/teamstepps-program/curriculum/mutual/overview/index.html.
Brach C, ed. Health Literacy Universal Precautions Toolkit. 3rd ed. Rockville, MD: Agency for Healthcare Research and Quality; 2024. AHRQ publication No. 23-0075. March 1, 2024. ahrq.gov/health-literacy/improve/precautions/toolkit.html
Ernstmeyer K, Christman E, eds. Nursing Pharmacology. 2nd ed. Eau Claire, WI: Chippewa Valley Technical College; 2023. ncbi.nlm.nih.gov/books/NBK595000
Ernstmeyer K, Christman E, eds. Nursing Skills. 2nd ed. Eau Claire, WI: Chippewa Valley Technical College; 2023. ncbi.nlm.nih.gov/books/NBK596735
Schroers G, Huggins E, Sasangohar F, O’Rourke J. Associations between interruptions and medication administration errors among nurses in hospital settings: A scoping review of quantitative studies. J Adv Nurs. 2026;82(4):2551-69. doi:10.1111/jan.70032
US Food & Drug Administration. Infusion pump risk reduction strategies for clinicians. February 2, 2018. fda.gov/medical-devices/infusion-pumps/infusion-pump-risk-reduction-strategies-clinicians
Williams R, Kantilal K, Man KKC, Blandford A, Jani Y. Barcode medication administration system use and safety implications: A data-driven longitudinal study supported by clinical observation. BMJ Health Care Inform. 2025;32(1):e101214. doi:10.1136/bmjhci-2024-101214
